Inpatient Prescribing and Monitoring of High Dose Anti-Psychotic Therapy Before and After Introduction of an Electronic Health Record.
Loading...
Authors
Doody, E
Dhubhlaing, C. N
O’Ceallaigh, S
Issue Date
2022
Type
Language
Keywords
Alternative Title
Abstract
Aims
To assess adherence to the hospital policy on high dose anti-psychotic (HDAT) prescribing and
monitoring.
Methods
Service users who were prescribed HDAT were identified. Clinical records were reviewed to
determine adherence to standards set out in hospital policy for prescribing and monitoring of HDAT.
The first cycle of this audit was performed in 2016. Following the introduction of an electronic health
record (EHR) system, cycle two was conducted in 2020.
Results
HDAT was prescribed for 6 service users in audit cycle one and 16 service users in audit cycle two.
Data was available for all 6 service users in the first audit cycle and for 15 service users in the second
audit cycle. All service users were consented prior to starting HDAT for both audit cycles. All
Individual Care Plans included mention of HDAT in cycle one, dropping to 7 (47%) in cycle two. All
service users had a repeat ECG performed where required after HDAT initiation in cycle one,
however, for cycle two only 6 (60%) of service users had a repeat ECG. While all service users of
childbearing potential had a pregnancy test in cycle one, 5 (83%) had a pregnancy test in cycle two.
After one month of HDAT prescription, 4 (40%) of service users had a repeat ECG and 7 (70%) had
repeat bloods in cycle two compared to 100% compliance in cycle one. HDAT use was poorly
documented in post-discharge correspondence for both audit cycles.
Discussion
Increasing ease-of-use of the EHR system may increase compliance in the future for clinical staff.
Description
Citation
Doody, E., Dhubhlaing, C. N., & O’Ceallaigh, S. (2022). Inpatient Prescribing and Monitoring of High Dose Anti-Psychotic Therapy Before and After Introduction of an Electronic Health Record. Ir Med J, 115(6), P612.